Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 9, Issue 6, Pages 1241-1253
Publisher
Informa UK Limited
Online
2013-04-06
DOI
10.4161/hv.24129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine
- (2012) Elizabeth E. Moran et al. Clinical and Vaccine Immunology
- Considerations for controlling invasive meningococcal disease in high income countries
- (2012) Johan Holst et al. VACCINE
- Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac
- (2012) François Caron et al. VACCINE
- Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles
- (2011) Xilian Bai et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease
- (2011) Ee Lyn Su et al. Expert Review of Vaccines
- Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine
- (2011) F. Marc LaForce et al. HEALTH AFFAIRS
- Meningococcal glycoconjugate vaccines
- (2011) Roberto Gasparini et al. Human vaccines & immunotherapeutics
- Next-generation outer membrane vesicle vaccines againstNeisseria meningitidisbased on nontoxic LPS mutants
- (2011) Peter van der Ley et al. Human vaccines & immunotherapeutics
- Reducing inequalities with vaccines: New Zealand's MeNZB vaccine initiative to control an epidemic
- (2011) Diana Lennon et al. JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak
- (2011) François Caron et al. LANCET INFECTIOUS DISEASES
- Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans
- (2011) Samba O. Sow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand
- (2011) Richard Arnold et al. VACCINE
- A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression
- (2011) P.B. Keiser et al. VACCINE
- Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide
- (2011) Wendell D. Zollinger et al. VACCINE
- Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development
- (2011) Rolando Pajon et al. PLoS Neglected Tropical Diseases
- Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease
- (2011) Michael Broeker et al. Infection and Drug Resistance
- Review of Meningococcal Group B Vaccines
- (2010) Dan M. Granoff CLINICAL INFECTIOUS DISEASES
- Serogroup B meningococcal vaccines—an unfinished story
- (2010) Manish Sadarangani et al. LANCET INFECTIOUS DISEASES
- Advances in the Development of Vaccines againstNeisseria meningitidis
- (2010) Lionel K.K. Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
- (2010) J. Donnelly et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease
- (2010) Han-Qing Jiang et al. VACCINE
- Fast Tracking the Vaccine Licensure Process to Control an Epidemic of Serogroup B Meningococcal Disease in New Zealand
- (2009) Diana Lennon et al. CLINICAL INFECTIOUS DISEASES
- Challenges and progress in the development of a serogroup B meningococcal vaccine
- (2009) Susan Lewis et al. Expert Review of Vaccines
- Sequence Diversity of the Factor H Binding Protein Vaccine Candidate in Epidemiologically Relevant Strains of Serogroup BNeisseria meningitidis
- (2009) Ellen Murphy et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine
- (2009) Sharon H. Wong et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
- (2009) Johan Holst et al. VACCINE
- Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
- (2009) Stefania Bambini et al. VACCINE
- Phase II meningococcal B vesicle vaccine trial in New Zealand infants
- (2008) C Jackson et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Henoch-Schonlein purpura and meningococcal B vaccination
- (2008) K Sexton et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years
- (2008) Y. Galloway et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Bactericidal Antibody Responses Elicited by a Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Factor H–Binding Protein and Genetically Attenuated Endotoxin
- (2008) Oliver Koeberling et al. JOURNAL OF INFECTIOUS DISEASES
- Two centuries of meningococcal infection: from Vieusseux to the cellular and molecular basis of disease
- (2008) A. L. de Souza et al. JOURNAL OF MEDICAL MICROBIOLOGY
- The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand
- (2008) Paul Stehr-Green et al. VACCINE
- The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand
- (2008) Michael V. Tatley et al. VACCINE
- MeNZB™ vaccine and epidemic control: When do you stop vaccinating?
- (2008) Belinda J. Loring et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now